American Academy of Neurology: Early Multiple Sclerosis Treatments Differ Most in Relapses and MRI Lesions, Not Disability
September 10, 2026
September 10, 2026
MINNEAPOLIS, Minnesota, Sept. 10 (TNSjou) -- The American Academy of Neurology issued the following news release:
* * *
Early MS treatments differ most in relapses and MRI lesions, not disability
Highlights:
* A study of 509 people newly diagnosed with MS found only small differences after two years, based on the first treatment they used.
* People taking B-cell treatments had fewer MS attacks and a small drop in MRI lesions compar . . .
* * *
Early MS treatments differ most in relapses and MRI lesions, not disability
Highlights:
* A study of 509 people newly diagnosed with MS found only small differences after two years, based on the first treatment they used.
* People taking B-cell treatments had fewer MS attacks and a small drop in MRI lesions compar . . .